-
1
-
-
0027197671
-
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma
-
Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, et al. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560.
-
(1993)
Biochem Biophys Res Commun
, vol.192
, pp. 553-560
-
-
Kitamura, K.1
Kangawa, K.2
Kawamoto, M.3
Ichiki, Y.4
Nakamura, S.5
-
2
-
-
0034453838
-
Adrenomedullin, a multifunctional regulatory peptide
-
Hinson JP, Kapas S, Smith DM, (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21: 138-167.
-
(2000)
Endocr Rev
, vol.21
, pp. 138-167
-
-
Hinson, J.P.1
Kapas, S.2
Smith, D.M.3
-
3
-
-
79960291828
-
Shared and separate functions of the RAMP-based adrenomedullin receptors
-
Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, et al. (2011) Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32: 1540-1550.
-
(2011)
Peptides
, vol.32
, pp. 1540-1550
-
-
Kuwasako, K.1
Kitamura, K.2
Nagata, S.3
Hikosaka, T.4
Takei, Y.5
-
5
-
-
33750609353
-
Adrenomedullin: a tumor progression factor via angiogenic control
-
Nakamura M, Han B, Nunobiki O, Kakudo K, (2006) Adrenomedullin: a tumor progression factor via angiogenic control. Curr Cancer Drug Targets 6: 635-643.
-
(2006)
Curr Cancer Drug Targets
, vol.6
, pp. 635-643
-
-
Nakamura, M.1
Han, B.2
Nunobiki, O.3
Kakudo, K.4
-
6
-
-
30644461078
-
Adrenomedullin and tumour angiogenesis
-
Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R, (2006) Adrenomedullin and tumour angiogenesis. Br J Cancer 94: 1-7.
-
(2006)
Br J Cancer
, vol.94
, pp. 1-7
-
-
Nikitenko, L.L.1
Fox, S.B.2
Kehoe, S.3
Rees, M.C.4
Bicknell, R.5
-
7
-
-
70449719302
-
[Calcium regulation of cell migration]
-
Pomorski P, (2009) [Calcium regulation of cell migration]. Postepy Biochem 55: 163-170.
-
(2009)
Postepy Biochem
, vol.55
, pp. 163-170
-
-
Pomorski, P.1
-
9
-
-
33846264865
-
TRP proteins and cancer
-
Bodding M, (2007) TRP proteins and cancer. Cell Signal 19: 617-624.
-
(2007)
Cell Signal
, vol.19
, pp. 617-624
-
-
Bodding, M.1
-
10
-
-
80052453345
-
TRP channels in prostate cancer: the good, the bad and the ugly?
-
Gkika D, Prevarskaya N (2011) TRP channels in prostate cancer: the good, the bad and the ugly? Asian J Androl.
-
(2011)
Asian J Androl
-
-
Gkika, D.1
Prevarskaya, N.2
-
11
-
-
81055144300
-
From urgency to frequency: facts and controversies of TRPs in the lower urinary tract
-
Skryma R, Prevarskaya N, Gkika D, Shuba Y, (2011) From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol 8: 617-630.
-
(2011)
Nat Rev Urol
, vol.8
, pp. 617-630
-
-
Skryma, R.1
Prevarskaya, N.2
Gkika, D.3
Shuba, Y.4
-
12
-
-
60849118922
-
Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation
-
Monet M, Gkika D, Lehen'kyi V, Pourtier A, Vanden Abeele F, et al. (2009) Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793: 528-539.
-
(2009)
Biochim Biophys Acta
, vol.1793
, pp. 528-539
-
-
Monet, M.1
Gkika, D.2
Lehen'kyi, V.3
Pourtier, A.4
Vanden Abeele, F.5
-
13
-
-
76249107718
-
Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance
-
Monet M, Lehen'kyi V, Gackiere F, Firlej V, Vandenberghe M, et al. (2010) Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 70: 1225-1235.
-
(2010)
Cancer Res
, vol.70
, pp. 1225-1235
-
-
Monet, M.1
Lehen'kyi, V.2
Gackiere, F.3
Firlej, V.4
Vandenberghe, M.5
-
14
-
-
47949123451
-
Transient Receptor Potential Vanilloid Type 2 (TRPV2) Expression in Normal Urothelium and in Urothelial Carcinoma of Human Bladder: Correlation with the Pathologic Stage
-
Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, et al. (2007) Transient Receptor Potential Vanilloid Type 2 (TRPV2) Expression in Normal Urothelium and in Urothelial Carcinoma of Human Bladder: Correlation with the Pathologic Stage. Eur Urol.
-
(2007)
Eur Urol
-
-
Caprodossi, S.1
Lucciarini, R.2
Amantini, C.3
Nabissi, M.4
Canesin, G.5
-
15
-
-
77955654605
-
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression
-
Gkika D, Flourakis M, Lemonnier L, Prevarskaya N, (2010) PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression. Oncogene 29: 4611-4616.
-
(2010)
Oncogene
, vol.29
, pp. 4611-4616
-
-
Gkika, D.1
Flourakis, M.2
Lemonnier, L.3
Prevarskaya, N.4
-
16
-
-
0030945144
-
Quantification of integrin subunits on human prostatic cell lines-comparison of nontumorigenic and tumorigenic lines
-
Haywood-Reid PL, Zipf DR, Springer WR, (1997) Quantification of integrin subunits on human prostatic cell lines-comparison of nontumorigenic and tumorigenic lines. Prostate 31: 1-8.
-
(1997)
Prostate
, vol.31
, pp. 1-8
-
-
Haywood-Reid, P.L.1
Zipf, D.R.2
Springer, W.R.3
-
17
-
-
0027074504
-
Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody
-
Fujita S, Suzuki H, Kinoshita M, Hirohashi S, (1992) Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody. Jpn J Cancer Res 83: 1317-1326.
-
(1992)
Jpn J Cancer Res
, vol.83
, pp. 1317-1326
-
-
Fujita, S.1
Suzuki, H.2
Kinoshita, M.3
Hirohashi, S.4
-
18
-
-
21744435478
-
The role of focal-adhesion kinase in cancer - a new therapeutic opportunity
-
McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, et al. (2005) The role of focal-adhesion kinase in cancer- a new therapeutic opportunity. Nat Rev Cancer 5: 505-515.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 505-515
-
-
McLean, G.W.1
Carragher, N.O.2
Avizienyte, E.3
Evans, J.4
Brunton, V.G.5
-
19
-
-
0034759617
-
The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC
-
Boels K, Glassmeier G, Herrmann D, Riedel IB, Hampe W, et al. (2001) The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC. J Cell Sci 114: 3599-3606.
-
(2001)
J Cell Sci
, vol.114
, pp. 3599-3606
-
-
Boels, K.1
Glassmeier, G.2
Herrmann, D.3
Riedel, I.B.4
Hampe, W.5
-
20
-
-
0037468266
-
Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis
-
Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, et al. (2003) Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 22: 1238-1242.
-
(2003)
Oncogene
, vol.22
, pp. 1238-1242
-
-
Ishikawa, T.1
Chen, J.2
Wang, J.3
Okada, F.4
Sugiyama, T.5
|